NEW YORK (GenomeWeb news) – Olink Bioscience said today that it has signed up Immuno Diagnostic to distribute its in situ protein detection systems in Finland.

Under the agreement, the Finnish company Immuno Diagnostic will distribute the Duolink in situ PLA product line, which is a proximity ligation assay technology that is used to detect proteins and their interactions and modifications. The technology allows for detection of target proteins with single-molecule resolution, Uppsala, Sweden-based Olink said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.